ANZCA, along with peak diabetes, obesity and gastroenterological bodies, has produced clinical practice recommendations for patients using GLP-1/GIP receptor agonists.

After early feedback from our continuing professional development (CPD) participants, we’ve released version 1.0.2. of our CPD app!

Darwin anaesthetist Dr Edith Waugh to examine Indigenous health care

We have a new structure to guide perioperative medicine into the future.

We are saddened by the passing of former ANZCA President Dr Richard (Dick) Willis AM. We send our condolences to his former colleagues, friends and family.

ANZCA’s statement on desflurane supports the continued education and actions to reduce usage.

New this month: GLP-1 Agonist guideline December review; ASA clinical guidance about GLP-1 Agonists; Perioperative mortality in New Zealand; webAIRS reaches 12,000 reported incidents.

The national shortage of IV fluid bags across multiple suppliers in Australia is ongoing and anticipated to continue until March 2025.

Generous donation expands the CTN pilot grant scheme

POM health care projects have been recognised in the 2024 Victorian Public Healthcare Awards.